Properties (52)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:Ophthalmic_products_from_Merck_&_Co.
Ophthalmic_business_from_Novartis |
| gptkbp:employs |
over 1,000 people
|
| gptkbp:focusesOn |
research and development
|
| gptkbp:founded |
1890
|
| gptkbp:hasPart |
manufacturing plants
R&D facilities sales offices |
| gptkbp:hasResearchFocus |
quality assurance
patient education patient safety telemedicine clinical trials medical devices patient-centered care safety monitoring collaborative research regenerative medicine biologics drug delivery systems pharmaceutical development global health initiatives post-marketing surveillance digital health solutions health economics innovative therapies pharmaceutical regulations sustainability in healthcare real-world evidence market access strategies surgical techniques access to medicines ocular diseases vision restoration healthcare_professional_training |
| gptkbp:hasSubsidiary |
gptkb:Santen_Inc.
gptkb:Santen_Pharmaceutical_Co.,_Ltd. |
| gptkbp:headquarters |
gptkb:Osaka,_Japan
|
| https://www.w3.org/2000/01/rdf-schema#label |
Santen Group
|
| gptkbp:operatesIn |
gptkb:Asia
gptkb:North_America Europe |
| gptkbp:partnerships |
with various universities
with healthcare organizations |
| gptkbp:products |
contact lens solutions
glaucoma medications anti-allergy eye drops dry eye treatments surgical products for eye care |
| gptkbp:revenue |
approximately $1 billion
|
| gptkbp:specializesIn |
ophthalmology
|